UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group

The lancet oncology, 2017-04, Vol.18 (4), p.454-463

2017

Link zum Volltext

Verfügbarkeit prüfen

Melanoma epidemiology, biology and prognosis

European journal of cancer supplements, 2013-09, Vol.11 (2), p.81-91

2013

Link zum Volltext

Verfügbarkeit prüfen

Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s

Radiotherapy and oncology, 2017-09, Vol.124 (3), p.365-369

2017

Link zum Volltext

Verfügbarkeit prüfen

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

Seminars in cancer biology, 2018-02, Vol.48, p.91-103

2018

Link zum Volltext

Verfügbarkeit prüfen

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

The lancet oncology, 2019-10, Vol.20 (10), p.e566-e581

2019

Link zum Volltext

Verfügbarkeit prüfen

A review of human carcinogens—Part F: Chemical agents and related occupations

The lancet oncology, 2009-12, Vol.10 (12), p.1143-1144

2009

Link zum Volltext

Verfügbarkeit prüfen

Nomograms in oncology: more than meets the eye

The lancet oncology, 2015-04, Vol.16 (4), p.e173-e180

2015

Link zum Volltext

Verfügbarkeit prüfen

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

The lancet oncology, 2019-08, Vol.20 (8), p.1148-1159

2019

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial ribosomes in cancer

Seminars in cancer biology, 2017-12, Vol.47, p.67-81

2017

Link zum Volltext

Verfügbarkeit prüfen

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment

Seminars in oncology, 2015-08, Vol.42 (4), p.663-671

Gajewski, Thomas F

2015

Link zum Volltext

Verfügbarkeit prüfen

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors

European journal of cancer supplements, 2013-09, Vol.11 (2), p.172-191

Schmidinger, Manuela

2013

Link zum Volltext

Verfügbarkeit prüfen

TCGA molecular groups of endometrial cancer: Pooled data about prognosis

Gynecologic oncology, 2019-11, Vol.155 (2), p.374-383

2019

Link zum Volltext

Verfügbarkeit prüfen

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1

Radiotherapy and oncology, 2016, Vol.118 (1), p.205-208

2016

Link zum Volltext

Verfügbarkeit prüfen

Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression

Seminars in cancer biology, 2018-02, Vol.48, p.36-52

Isakov, Noah

2018

Link zum Volltext

Verfügbarkeit prüfen

Multiple myeloma epidemiology and survival: A unique malignancy

Seminars in oncology, 2016-12, Vol.43 (6), p.676-681

Kazandjian, Dickran

2016

Link zum Volltext

Verfügbarkeit prüfen

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

The lancet oncology, 2017-03, Vol.18 (3), p.e143-e152

2017

Link zum Volltext

Verfügbarkeit prüfen

Voice Rehabilitation After Total Laryngectomy and Postoperative Radiation Therapy

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S454-S455

2013

Link zum Volltext

Verfügbarkeit prüfen

Chimeric antigen receptor T cell therapy: 25 years in the making

Blood reviews, 2016-05

2016

Link zum Volltext

Verfügbarkeit prüfen

A review of human carcinogens—Part D: radiation

The lancet oncology, 2009-08, Vol.10 (8), p.751-752

2009

Link zum Volltext

Verfügbarkeit prüfen

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

The lancet oncology, 2016-11, Vol.17 (11), p.1509-1520

2016

Link zum Volltext

Verfügbarkeit prüfen

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

The lancet oncology, 2016-08, Vol.17 (8), p.e328-e346

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 177.158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163.096)
Mit Volltextzugriff
(175.917)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(176.886)
Japanisch
(12.938)
Spanisch
(259)
Portugiesisch
(21)
Polnisch
(14)
Russisch
(10)
Chinesisch
(7)
Französisch
(4)
Norwegisch
(2)
Deutsch
(2)
Afrikaans
(1)

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Hematology, Oncology And Palliative Medicine
(175.000)
Science & Technology
(72.245)
Life Sciences & Biomedicine
(72.231)
Humans
(68.871)
Oncology
(58.543)
Female
(39.163)
Radiology
(37.594)
Male
(29.623)
Middle Aged
(27.949)
Aged
(24.293)
Adult
(21.872)
Hematology
(18.860)
Radiology, Nuclear Medicine & Medical Imaging
(12.636)
Aged, 80 And Over
(11.324)
Surgery
(10.767)
Treatment Outcome
(10.611)
Obstetrics And Gynecology
(10.600)
Biological And Medical Sciences
(10.556)
Medical Sciences
(10.518)
Tumors
(10.462)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier ScienceDirect Journals Complete
(169.861)
IngentaConnect
(165.054)
IngentaConnect Journals
(159.397)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(125.057)
EZB Free E-Journals
(26.008)
NUS Single-Journal Subscriptions
(11.717)
Journals@Ovid Complete
(7.266)
ScienceDirect eBooks
(1.796)
Ebook Central Perpetual and DDA
(1.718)
SpringerLink (Online service)
(1.685)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.665)
eBooks on EBSCOhost
(1.626)
Applied Social Sciences Index & Abstracts (ASSIA)
(477)
Nexis
(21)
Wiley Online Library
(15)
SAGE Complete
(15)
BMJ Journals
(13)
Nature
(13)
Taylor & Francis:Master (3349 titles)
(12)
Wiley Online Library Full Collection 2018
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

International Journal Of Radiation Oncology, Biology, Physics
(28.624)
Radiotherapy And Oncology
(17.568)
European Journal Of Cancer
(15.332)
Biology Of Blood And Marrow Transplantation
(9.573)
European Journal Of Cancer Supplements
(9.097)
Gynecologic Oncology
(8.965)
European Journal Of Surgical Oncology
(6.804)
Thrombosis Research
(5.914)
Leukemia Research
(5.715)
Lung Cancer
(5.426)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group

Melanoma epidemiology, biology and prognosis

Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

A review of human carcinogens—Part F: Chemical agents and related occupations

Nomograms in oncology: more than meets the eye

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Mitochondrial ribosomes in cancer

The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

TCGA molecular groups of endometrial cancer: Pooled data about prognosis

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1

Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression

Multiple myeloma epidemiology and survival: A unique malignancy

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

Voice Rehabilitation After Total Laryngectomy and Postoperative Radiation Therapy

Chimeric antigen receptor T cell therapy: 25 years in the making

A review of human carcinogens—Part D: radiation

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Suchergebnisse filtern